Ariosa Diagnostics Expands Harmony Prenatal Test to Twin Pregnancies and Launches New X,Y Analysis Test

Share Article

New Innovations to the Harmony Prenatal Test Now Allow for X,Y Analysis and Twin Pregnancies.

News Image

Ariosa Diagnostics, maker of the non-invasive Harmony™ Prenatal Test for risk assessment of Down syndrome and other chromosome conditions, has announced today the expanded indication for testing of twin pregnancies naturally conceived or conceived using the patient’s own egg.

In addition, Ariosa will be offering fetal X,Y analysis as an option to those women electing to have the Harmony test. This new test allows for the evaluation of fetal sex and sex chromosome genetic conditions such as Turner syndrome and Klinefelter syndrome. Sex chromosome conditions can be associated with various medical issues, but can also be found in individuals with no apparent clinical effect.

“Our goal at Ariosa has always been to improve patient care for expectant mothers and this new offering further expands upon the options we have added to the Harmony test since the beginning of the year,” said Ken Song, MD, CEO of Ariosa. “It is important that healthcare providers and patients be sufficiently educated on the benefits and limitations of NIPT. In the case of assessing risk for fetal sex chromosomal conditions, proper counseling is essential prior to testing, as only a subset of women are likely to truly benefit from such testing.”

Earlier this year, Ariosa began offering the Harmony with Y-chromosome analysis test option and announced the expansion of the Harmony test to allow for both self and non-self IVF pregnancies. The Harmony test assesses risk of Down syndrome with greater than 99% accuracy and also provides information on other trisomy conditions.

###

About Ariosa Diagnostics
Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit http://www.ariosadx.com. Follow us on Twitter @HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jenny Davis
Dotted Line Communications
(925) 935-2558
Email >